Estela Rodriguez: Check out the latest-much needed ASCO Guidelines on Functional Neuroendocrine Tumors
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, shared a post by Aman Chauhan, Leader of Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, adding:
“Check out the latest-much needed -ASCO Guidelines on functional neuroendocrine tumors NETs – a disease with a lot of nuance in diagnosis and treatment.”
Quoting Aman Chauhan‘s post:
“Check out the latest ASCO guidelines on functional NETs. While management of well-differentiated NETs is often nuanced, three critical factors should be assessed at the initial visit to guide an effective treatment plan:
Tumor Grade
Disease Stage
Functional Status.”
Title: Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
Authors: Kimberly Perez, Jaydira Del Rivero, Erin B. Kennedy, Sandip Basu, Aman Chauhan, Heidi M. Connolly, Arvind N. Dasari, Alexandra Gangi, Callisia N. Clarke, Julie Hallet, James R. Howe, Erin Grady, Jana Ivanidze, Erik S. Mittra, Sarah B. White, Nitya P. Raj, Namrata Vijayvergia, Mark A. Lewis, Jennifer A. Chan, Pamela L. Kunz, Josh Mailman, Junaid Arshad, Heloisa P. Soares, Simron Singh, Chandrika Chandrasekharan, Michael C. Soulen, Eva Tiensuu Janson, Thorvardur R. Halfdanarson, Jonathan R. Strosberg, Emily K. Bergsland
Read the Full Article in JCO Oncology Practice.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023